EFFICACY AND TOLERABILITY OF LEVODROPROPIZINE AND DROPROPIZINE IN CHILDREN WITH NONPRODUCTIVE COUGH

被引：32

作者：

BANDERALI, G

RIVA, E

FIOCCHI, A

CORDARO, CI

GIOVANNINI, M

机构：

[1] DOMPE FARMACEUT SPA,I-20122 MILAN,ITALY

[2] UNIV MILAN,SCH MED,DEPT PAEDIAT 5,MILAN,ITALY

来源：

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1995年 / 23卷 / 03期

关键词：

LEVODROPROPIZINE; DROPROPIZINE; COUGH; ANTITUSSIVES; SOMNOLENCE;

D O I：

10.1177/030006059502300304

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The antitussive efficacy and tolerability of dropropizine and of its enantiomer levodropropizine were evaluated in children with non-productive cough; 258 were evaluable for tolerability and 254 for efficacy. Patients randomly received either 1 mg/kg dropropizine or 2 mg/kg levodropropizine orally, three times daily for 3 days. There were statistically significant decreases in the frequency of coughing spells and nocturnal awakenings after both levodropropizine and dropropizine treatments (P < 0.001). Gastro-intestinal symptoms were mild in the two groups; somnolence was twice as frequent in the dropropizine group (10.3% vs 5.3%) and the difference is clinically relevant, though not statistically significant. Levodropropizine is as effective as an antitussive as dropropizine, but appears to carry a lower risk of daytime somnolence.

引用

页码：175 / 183

页数：9

共 21 条

[1]

Malandrino S., Melillo G., Bestetti A., Antitussive properties of levodropropizine, Arzneim Forsch, 38, pp. 1141-1143, (1988)

[2]

Munt P.L., Clavenna G., Algate D.R., Antitussive effects of levodropropizine in the dog, Arzneim Forsch, 44, pp. 153-155, (1994)

[3]

Melillo G., Lavezzo A., Bestetti A., Levodropropizine (LF 526), a new antitussive compound with antiallergic property, Pharmacol Res Commun, 20, (1988)

[4]

Lavezzo A., Bossi R., Melillo G., Antibronchospastic and antiallergic activities of levodropropizine in animals and asthmatic allergic hyperreactive patients, Eur J Clin Pharmacol, 36, (1989)

[5]

Folkerts G., Van der Linde H.J., Omini C., Virus-induced airway inflammation and hyperresponsiveness in the guineapig is inhibited by levodropropizine, Naunyn-Schmiedebergs Arch Pharmacol, 348, pp. 213-219, (1993)

[6]

Daffonchio L., Hernandez A., Melillo G., Effectiveness of levodropropizine against cigarette smoke-induced airway hyperreactivity: Possible mechanism, Eur J Pharmacol, 228, pp. 257-261, (1993)

[7]

Melillo G., Malandrino S., Rossoni G., General pharmacology of the new antitussive levodropropizine, Arzneim Forsch, 38, pp. 1144-1150, (1988)

[8]

Gatti G., Barzaghi N., Dominijanni R., Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: A placebo controlled, double-blind comparative study, Drugs Exp Clin Res, 19, pp. 33-39, (1993)

[9]

Boselli G., Studio clinico di attività e tollerabilità della dropropizina, Minerva Med, 63, pp. 2782-2788, (1972)

[10]

Allegra L., Bossi R., Clinical trials with the new antitussive levodropropizine in adult bronchitic patients, Arzneim Forsch, 38, pp. 1163-1166, (1988)

← 1 2 3 →